Form 4: Hologic Merger Completes, Executive Ownership Changes

Hologic Inc. has completed its merger, resulting in changes to executive beneficial ownership and the conversion of stock options and units into cash and contingent value rights.

Summary

• This filing reports changes in beneficial ownership for Anne M. Liddy, General Counsel of Hologic Inc., following the completion of a merger.
• The merger, effective April 7, 2026, involved Hologic Inc. merging with Hopper Merger Sub Inc., a subsidiary of Hopper Parent Inc.
• Each share of Hologic common stock was converted into $76.00 in cash and one contingent value right (CVR) potentially worth up to $3.00.
• Executive stock options and performance stock units were cancelled and converted into rights to receive the merger consideration.
• As a result of the merger, Anne M. Liddy no longer beneficially owns any shares of Hologic common stock directly or indirectly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting on the mechanics of a completed merger and its impact on executive ownership, rather than providing new operational or financial performance data.

Positives

• The merger consideration of $76.00 per share in cash provides a significant immediate return to shareholders.
• The inclusion of a contingent value right (CVR) offers potential for additional upside if certain performance milestones are met.

Negatives

• All previously held common stock, stock options, and performance stock units are cancelled as part of the merger, eliminating direct future equity participation for executives in the combined entity.
• The value of the CVR is contingent and not guaranteed, introducing an element of uncertainty for potential additional proceeds.

Risks

• The value of the contingent value right (CVR) is subject to future performance and may not be fully realized.
• The filing indicates that stock options with an exercise price equal to or greater than $79.00 were cancelled for no consideration, representing a loss for those option holders.

Future Outlook

The future outlook for Hologic Inc. is now tied to the performance of the acquiring entity and the realization of value from the contingent value rights (CVRs). Specific forward-looking guidance is not provided in this Form 4 filing.

Management Comments

• The filing details the conversion of various equity awards into cash and CVRs as per the merger agreement, indicating a structured transition following the acquisition.

Industry Context

StockSavvy.ai notes that this Form 4 filing reflects a common outcome in acquisition scenarios where executive and employee equity awards are cashed out or converted, signaling the completion of a significant corporate transaction in the medical technology sector.

Stakeholder Impact

• Shareholders: Received $76.00 per share in cash plus a CVR, providing immediate liquidity and potential for further gains.
• Employees (including executives): Stock options and RSUs were converted into cash and/or CVRs, changing their compensation structure from equity-based to cash-based.
• Creditors: The acquisition may alter the capital structure and debt obligations of the combined entity, though specific impacts are not detailed in this filing.

Next Steps

• Shareholders and option holders will receive the specified cash consideration and contingent value rights.
• The company will operate as a wholly owned subsidiary of Hopper Parent Inc.

Key Dates

Keywords

Hologic Inc., Merger, Form 4, Beneficial Ownership, Stock Options, Performance Stock Units, Contingent Value Right, SEC Filing, Executive Compensation, Acquisition